| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 30, 651-662, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
GM Fless, ML Snyder and AM Scanu
Department of Medicine, Pritzker School of Medicine, University of Chicago, IL 60637.
Based on our findings that rabbit antisera raised against human Lp[a] or apo[a] have the potential to cross-react with plasminogen, and in some cases have nearly equal affinities for plasminogen and Lp[a], we have developed an assay for plasma Lp[a] based on a "sandwich" ELISA that is insensitive to the presence of plasminogen. This was accomplished through the use of anti-apo[a] as a capture antibody and quantitation of the bound Lp[a], i.e., the apoB-100-apo[a] complex, with an anti-apoB antibody. Although apo[a] is heterogeneous in size, all Lp[a] particles tested, either in pure form or contained in whole plasma, gave parallel dose-response curves and were immunologically equivalent. However, when purified Lp[a] particles with different apo[a] isoforms were studied, those having larger isoforms were, on a weight basis, less reactive than those having a smaller size. Nearly equivalent reactivity was observed when protein concentration was expressed on a molar basis. The distribution of Lp[a] in a population of 84 subjects was skewed with one-third of the individuals having less than 1 mg/dl Lp[a] protein. All subjects tested had measurable concentrations of Lp[a] with a lower limit of detection of 0.030 mg/dl Lp[a] protein. The mean level was 3.2 mg/dl with a range of 0.045 to 13.3 mg/dl. These studies demonstrate the successful development of an ELISA for Lp[a] protein that is insensitive to the presence of plasminogen; that heterogeneity of Lp[a] and apo[a] are an important source of variation in the assay; and the need for an appropriate Lp[a] standard in order to minimize this variation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Smolders, R. Lemmens, and V. Thijs Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies Stroke, June 1, 2007; 38(6): 1959 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Edelstein, M. Yousef, and A. M. Scanu Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin J. Lipid Res., December 1, 2005; 46(12): 2673 - 2680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Formato, M. Farina, R. Spirito, M. Maggioni, A. Guarino, G. M. Cherchi, P. Biglioli, C. Edelstein, and A. M. Scanu Evidence for a Proinflammatory and Proteolytic Environment in Plaques From Endarterectomy Segments of Human Carotid Arteries Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Edelstein, D. Pfaffinger, J. Hinman, E. Miller, G. Lipkind, S. Tsimikas, C. Bergmark, G. S. Getz, J. L. Witztum, and A. M. Scanu Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a) J. Biol. Chem., December 26, 2003; 278(52): 52841 - 52847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Klezovitch, C. Edelstein, and A. M. Scanu Stimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a). EVIDENCE FOR A CRITICAL INVOLVEMENT OF ELEMENTS IN ITS C-TERMINAL DOMAIN J. Biol. Chem., December 7, 2001; 276(50): 46864 - 46869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Edelstein, K. Nakajima, D. Pfaffinger, and A. M. Scanu Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins J. Lipid Res., October 1, 2001; 42(10): 1664 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakajima, J. Hinman, D. Pfaffinger, C. Edelstein, and A. M. Scanu Changes in Plasma Triglyceride Levels Shift Lipoprotein(a) Density in Parallel With That of LDL Independently of Apolipoprotein(a) Size Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1238 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Edelstein, S. D. Shapiro, O. Klezovitch, and A. M. Scanu Macrophage Metalloelastase, MMP-12, Cleaves Human Apolipoprotein(a) in the Linker Region between Kringles IV-4 and IV-5. POTENTIAL RELEVANCE TO LIPOPROTEIN(a) BIOLOGY J. Biol. Chem., April 9, 1999; 274(15): 10019 - 10023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Fless, E. W. Kirk, O. Klezovitch, J. Y. Santiago, C. Edelstein, J. Hoover-Plow, and A. M. Scanu Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a] J. Lipid Res., April 1, 1999; 40(4): 583 - 592. [Abstract] [Full Text]
|
|
|
|
|
|
O. Klezovitch, C. Edelstein, L. Zhu, and A. M. Scanu Apolipoprotein(a) Binds via Its C-terminal Domain to the Protein Core of the Proteoglycan Decorin. IMPLICATIONS FOR THE RETENTION OF LIPOPROTEIN(a) IN ATHEROSCLEROTIC LESIONS J. Biol. Chem., September 11, 1998; 273(37): 23856 - 23865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Edelstein, J. A. Italia, and A. M. Scanu Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase. GENERATION OF mini-Lp(a) PARTICLES AND apo(a) FRAGMENTS J. Biol. Chem., April 25, 1997; 272(17): 11079 - 11087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Bonen, A. M.L. Hausman, C. Hadjiagapiou, S. F. Skarosi, and N. O. Davidson Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells. EVIDENCE FOR INTRACELLULAR ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., February 28, 1997; 272(9): 5659 - 5667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Cianflone, Z. Zhang, H. Vu, R. Kohen-Avramoglu, D. Kalant, and A. D. Sniderman The Effect of Individual Amino Acids on ApoB100 and Lp(a) Secretion by HepG2 Cells J. Biol. Chem., November 15, 1996; 271(46): 29136 - 29145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Superko Beyond LDL Cholesterol Reduction Circulation, November 15, 1996; 94(10): 2351 - 2354. [Full Text]
|
|
|
|
|
|
S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age Circulation, September 15, 1996; 94(6): 1263 - 1268. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Hoover-Plow, N. Boonmark, P. Skocir, R. Lawn, and E. F. Plow A Quantitative Immunoassay for the Lysine-Binding Function of Lipoprotein(a) : Application to Recombinant Apo(a) and Lipoprotein(a) in Plasma Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 656 - 664. [Abstract] [Full Text]
|
|
|
|
|
|
K. Makino, J. W. Furbee Jr, A. M. Scanu, and G. M. Fless Effect of Glycation on the Properties of Lipoprotein(a) Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 385 - 391. [Abstract] [Full Text]
|
|
|
|
 |
|
 G Utermann The mysteries of lipoprotein(a) Science, November 17, 1989; 246(4932): 904 - 910. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
